Knockout of the C4BPA Gene Promotes Mitophagy via Activation of the Pink1/Parkin Pathway and Alleviates the Inflammatory Response by Inhibiting the NF-κB Signalling Pathway in Bovine Mammary Epithelial Cells
Yanlong Zhou, Zhihui Zhao, Xuanxu Chen, Weihua Shao, Qiwen Lu, Qiuyan Tao, Qianchao Xu, Ruiwen Chen, Ping Jiang, Ziwei Lin, Haibin Yu

TL;DR
Disabling the C4BPA gene in cow mammary cells reduces inflammation and activates a process that clears damaged mitochondria, offering new ways to combat mastitis.
Contribution
This study reveals that C4BPA gene knockout activates mitophagy and suppresses inflammation in bovine mammary epithelial cells.
Findings
C4BPA knockout reduces pro-inflammatory cytokines like TNF-α, IL-1β, and IL-6 in bovine mammary epithelial cells.
C4BPA deficiency activates Pink1/Parkin-mediated mitophagy and suppresses NF-κB signaling, reducing inflammation.
Knockout of C4BPA increases ROS levels and alters mitochondrial morphology, promoting mitophagy.
Abstract
Animal health and milk quality are both adversely affected by mastitis, a frequently occurring udder condition in dairy cattle. This study focused on the bovine C4BPA gene to explore whether it could be a key to combating mastitis. We found that deactivating C4BPA in bovine mammary epithelial cells reduces inflammatory factor levels. Additionally, deactivating this gene alters mitochondrial structure and morphology and increases the levels of reactive oxygen species. These changes trigger a cellular process called mitophagy, which results in the clearance of damaged mitochondria. Most importantly, we found that this clearance process helps alleviate inflammation. In short, our research demonstrates that the C4BPA gene regulates both mitophagy and inflammation. Leveraging this mechanistic understanding, the present work proposes novel molecular targets for the prediction of bovine…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5- —National Natural Science Foundation of China
- —Natural Science Foundation of Guangdong Province
- —Key Laboratory of Animal Resources and Breed Innovation in West Guangdong
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMilk Quality and Mastitis in Dairy Cows · Autophagy in Disease and Therapy · Neutrophil, Myeloperoxidase and Oxidative Mechanisms
1. Introduction
The complement system, as a core innate immune component for host defence and clearance of immune complexes, executes important biological functions to resist bovine mastitis [1,2]. To maintain the delicate balance of immunity and tolerance and prevent excessive activation of the complement system, complement inhibitors are essential [3]. C4b-binding protein (C4BP) is a complement-regulatory factor and major liquid-phase inhibitor [4]. It is composed of two different polypeptides—a 70 kDa α chain and a 45 kDa β chain—which, respectively, enable it to bind and inactivate vitamin K-dependent protein S [5]. C4b-binding protein alpha (C4BPA) also functions as an atypical regulator of NF-κB-dependent cell death [6].
Mastitis, a relatively common disease in dairy farming, refers to an infection of the udder and is primarily attributed to pathogenic bacteria or environmental factors [7]. This disease not only severely affects dairy cows’ productivity, health, and welfare, but also places a considerable financial burden on dairy production [8]. Mastitis in dairy cows is classically characterized by udder redness, swelling, heat, and pain. In addition, mastitis reduces the quality of milk, resulting in decreases in its protein and fat contents [9,10,11,12,13]. In severe cases, affected cows may even lose their lactation capacity [14]. Treating mastitis also incurs the costs of medicine and veterinary treatment. Consequently, extensive research has been focused on enhancing mastitis resistance through breeding.
Mastitis is accompanied by an inflammatory response in mammary gland tissue [15]. Research indicates that the mastitis-induced inflammatory response is characterized via inflammatory cytokine secretion—namely tumour necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and interleukin-6 (IL-6)—and reactive oxygen species (ROS) [16]. Bovine mammary epithelial cells (BMECs) are characterized by their dual capacity for milk secretion and for providing the initial defence against pathogens [17]. The process of milk secretion is fuelled by mitochondria through the production of copious ATP. Mitochondria are important organelles for maintaining cellular homeostasis and very important for regulating endogenous cellular inflammation [18,19]. Mitochondrial dysfunction and the inflammatory response are closely correlated [20]. Mitophagy is essential for controlling the quantity of mitochondria within cells and maintaining their normal function and structure, thereby ensuring cellular and organismal homeostasis [21]. Moreover, mitophagy is associated with mastitis. Li et al. [22] reported that Lactobacillus rhamnosus GR-1 prevented Escherichia coli-induced inflammation in bovine mastitis through Pink1-/Parkin-mediated mitophagy.
Our previous studies revealed that the key parameters including inflammatory factor expression and NF-κB pathway activity were altered by transfection of C4BPA interference or overexpression vectors into BMECs [23]. While interference with C4BPA expression shows potential in suppressing the inflammatory response, the underlying mechanisms of this phenomenon require further investigation.
Therefore, to investigate how C4BPA deficiency affects the cellular inflammatory response, in this study, we utilized a C4BPA knockout cell line. This study may provide novel potential molecular targets for predicting bovine mastitis.
2. Materials and Methods
2.1. Cell Culture
Bovine mammary epithelial cells (BMECs) and the C4BPA knockout line, were provided by the Laboratory of Animal Molecular Genetics at Guangdong Ocean University’s College of Coastal Agricultural Sciences. The C4BPA knockout cell line was constructed by designing sgRNAs targeting the bovine C4BPA gene using an online tool, followed by cloning them into an EGFP-puro plasmid, enriching positive cells via transfection and fluorescence-activated cell sorting (FACS), and finally confirming the knockout through DNA extraction and verification [24]. The wild-type (WT) control consisted of BMECs. All the cells were maintained in DMEM/F-12 medium (HyClone, Logan, UT, USA) supplemented with 10% foetal bovine serum (FBS) (Zeta Life, Menlo Park, CA, USA) in an incubator (37 °C, 5% CO_2_). Prior to various experiments, the two cell types were prepared by culturing for 24 h. The ethical guidelines of Guangdong Ocean University governed all procedures in this study.
2.2. RNA Isolation and qPCR
Total RNA extraction from bovine mammary epithelial cells was performed with the MolPure TRIeasy Plus Total RNA Kit (Yeasen, Shanghai, China). All steps were carried out as directed by the manufacturer. Reverse transcription was carried out to synthesize cDNA from total RNA, employing HiScript III RT SuperMix for qPCR (+gDNA wiper) (Vazyme, Nanjing, China). Quantitative PCR analysis was carried out using ChamQ Universal SYBR qPCR Master Mix (Vazyme, Nanjing, China) on a QuantStudio 1 system (Thermo Fisher Scientific, Waltham, MA, USA), following the recommended protocols. Following normalization to β-actin (internal control), relative gene expression was analyzed by the 2^−ΔΔCt^ method. Furthermore, the qPCR primer sequences designed and used in this study are summarized in Table 1.
2.3. ELISA
Expressions of the proteins IL-1β, IL-6, TNF-α and TLR4 of two groups were detected using ELISA kits (MEIMIAN, Yancheng, China). After a fivefold dilution, 100 μL of HRB detection antibody was added, followed by incubation at 37 °C according to the manual. Following five wash cycles, Substrates A and B were added to the wells. After incubation, the stop solution was added and absorbance readings were taken.
2.4. Antibodies and Western Blotting
Protein was extracted using ice-cold RIPA lysis buffer (Beyotime, Shanghai, China) supplemented with 1% inhibitor (Beyotime, Shanghai, China). Measurement of protein concentration was performed with the BCA protein assay kit (Takara, Shiga, Japan). Protein denaturation was achieved by incubation with SDS–PAGE sample loading buffer (5×) (Beyotime, Shanghai, China). After SDS-PAGE, proteins were electrophoretically transferred to PVDF membranes (Millipore, Billerica, MA, USA). After blocking, the membranes were incubated with antibodies. Following another three washes, the chemiluminescence signals were detected in a chemiluminescence system (Bio-Rad, Marnes-la-Coquette, France) and analysed with ImageJ 1.51j8 software (National Institutes of Health, Bethesda, MD, USA). Information on the antibodies used in this experiment is presented in Table 2.
2.5. Reactive Oxygen Species Detection (ROS)
The intracellular ROS levels of each group of cells were detected using an ROS detection kit (Beyotime, Shanghai, China). The cells were digested with trypsin (HyClone, Logan, UT, USA) and collected. At 37 °C, cells in both groups were incubated with 10 µM DCFH-DA for probe loading. ROS were detected on a flow cytometer (BECKMAN COULTER, Shanghai, China) using the FITC-A channel.
2.6. Transmission Electron Microscopy (TEM)
After the cells of the two groups were centrifuged and collected, they were resuspended and homogenously fixed in electron microscopy fixative (PINUOFEI BIOLOGICAL, Wuhan, China) at 4 °C. Then, they were washed by homogenous mixing with phosphate buffer PB, and a 1% agarose solution was prepared for pre-embedding. The samples were subsequently fixed with 1% osmium tetroxide in the dark at room temperature for 2 h, followed by gradient ethanol dehydration. Acetone and 812 embedding agent (SPI Supplies, West Chester, PA, USA) were used in proportion for infiltration, embedding, and resin polymerization. After being sectioned into ultrathin slices with an ultrathin microtome, collected on 150-mesh copper grids, stained, and observed under a transmission electron microscope (Hitachi, Tokyo Metropolis, Japan), after which images were collected for analysis.
2.7. Immunofluorescence
For permeabilization, both groups of log-phase cells, placed in 12-well plates, were treated with a permeabilization solution and incubated at room temperature. After washing with PBS, antibody incubation was performed following the same protocol as for Western blotting. Finally, they were counterstained with DAP (Pinuofei, Wuhan, China) for nuclear visualization. An inverted optical microscope (Nikon, Tokyo, Japan) and a confocal microscope (Nexcope, Ningbo, China) were used to acquire images. Antibody information is listed in Table 3.
2.8. Statistical Analysis
Values were expressed as mean ± SD. Each experiment was performed in triplicate. The experimental data were analysed and plotted using GraphPad Prism software 8 (Version X, La Jolla, CA, USA). Student’s t-test was used for comparisons between two groups, and a p value < 0.05 indicated a significant difference.
3. Results
3.1. Validation of C4BPA Knockout Cell Lines
To validate the efficiency of the C4BPA gene knockout in the BMEC lines, we conducted immunofluorescence staining experiments on the WT and KO cells. In the WT group (Figure 1), C4BPA (labelled in red) exhibited a distinct distribution pattern. However, in the KO group, only weak red fluorescence was detected, indicating that the knockout in the KO group was highly effective.
3.2. Effects of the C4BPA Gene on the Expression of Inflammatory Cytokines in BMECs
The inflammatory role of the C4BPA gene was assessed by measuring the mRNA and protein expressions of TLR4 and relevant inflammatory factors. Compared with the WT group, the KO group displayed significant reductions in the mRNA expressions of TLR4 and inflammatory factors (Figure 2A–D) (p < 0.05). The ELISA results exhibited the same trend for TLR4 and inflammatory factors expressions after C4BPA gene knockout in BMECs (Figure 2E–H) (p < 0.05). Our data demonstrate that knockout of the C4BPA gene inhibits the inflammatory response in BMECs.
3.3. Effects of C4BPA on Mitochondrial Morphology in BMECs
To explore the subcellular localization of C4BPA and determine whether its knockout affects the mitochondrial morphology, we performed immunofluorescence staining and TEM on both groups of cells. As shown in Figure 3A, C4BPA partially colocalized with the mitochondria, as demonstrated by the overlapping yellow–green signals. A quantitative analysis of the fluorescence intensity along a specific line (intensity–distance profile) showed that in the wild-type cells, the intensity profiles of C4BPA and TOM20 displayed overlapping peaks in specific regions; conversely, in the KO cells, such overlap was not observed, further validating the above findings. Collectively, these results suggest the presence of a potential interaction or spatial proximity between C4BPA and mitochondria.
Our microscopy observations (Figure 3B) also revealed that both the WT and KO cells predominantly exhibited a cobblestone-like morphology, with a moderate number of organelles. The nuclei (N) were all elliptical, the nucleoli (Nu) were not distinct, and some parts of the nuclear surface showed slight invagination. The nuclear membranes were intact but somewhat blurred in certain areas, and no obvious widening of the perinuclear space was observed. However, more autolysosomes (ALs) were observed in the cytoplasm in the KO group than in the WT group. Moreover, in the KO cells, some mitochondrial (M) matrices were pale and indistinct, with extensive dissolution. The cristae exhibited fractures and were present in lower numbers. In some instances of severe damage, the organellar membrane structures were disrupted, and some organelles were conspicuously swollen.
On the basis of the above findings, we examined the ROS levels in both cell groups (Figure 3C) and found that the intracellular ROS levels were significantly increased following C4BPA knockout. Consequently, the altered mitochondrial structure and morphology induced by C4BPA knockout led to the generation of intracellular ROS.
3.4. Effects of the C4BPA Gene on Mitophagy in BMECs
Western blot analysis revealed that C4BPA knockout significantly altered the expression of mitophagy markers (Figure 4A,B). Specifically, it was associated with upregulation of Pink1 and Parkin, downregulation of P62, and an increased LC3B-II/LC3B-I ratio. In addition, immunofluorescence analysis (Figure 4C) revealed that the yellow fluorescence signal of LC3 and TOM20 colocalization was significantly enhanced after C4BPA gene knockout. These findings suggest that C4BPA gene knockout effectively promotes mitophagy.
3.5. Effects of C4BPA on the NF-κB Signalling Pathway in BMECs
Given the crucial role of NF-κB signalling in the inflammatory response, to further explore the regulatory impact of the C4BPA gene on inflammatory factors, we detected the protein expression related to the NF-κB signalling pathway. The results revealed that IκBα and p65 significantly increased after C4BPA gene knockout, whereas those of P-IκBα and P-p65 decreased (Figure 5A). In addition, the P-IκBα/IκBα, and P-p65/p65 also decreased significantly (Figure 5B). These findings suggest that C4BPA gene knockout can effectively inhibit the activation of the NF-κB signalling pathway.
4. Discussion
Mastitis is a common disease in dairy cows that severely affects their health and production performance [25]. Dairy cows with mastitis usually exhibit mammary gland inflammation. In our previous study, transfection of C4BPA interference or overexpression vectors altered inflammatory cytokine levels in BMECs. Therefore, we speculated that C4BPA is involved in the inflammatory response in BMECs. Our current findings reveal that C4BPA deficiency in BMECs not only promotes mitophagy by activating the Pink1/Parkin pathway but also alleviates the inflammatory response by suppressing the NF-κB pathway, thereby leading to reduced levels of inflammatory cytokines.
The inflammatory response serves as an organismal defence mechanism in response to external stimuli [26]. Mastitis causes the release of various cytokines, such as TNF-α, IL-1β, and IL-6, in mammary gland tissue, promoting the development of the inflammatory response [27]. Zhao et al. [28] reported that dairy cows with subclinical mastitis (SCM) exhibited significantly increased serum levels of inflammatory cytokine, and TNF-α; conversely, these levels decreased significantly following treatment with Gongying San (GYS), indicating an anti-inflammatory effect. Therefore, a decrease in inflammatory factors reflects the inhibition of the inflammatory response. Building on previous studies, in this study, we examined the TLR4 and the inflammatory factors expression levels in C4BPA gene knockout cell lines. The results showed that compared with normal BMECs, the expressions of TLR4 and the inflammatory factors were greatly reduced after knockout of the C4BPA gene. This suggests that knocking out the C4BPA gene can effectively suppress the inflammatory response in BMECs.
Mitochondria serve as the central hubs of cellular energy metabolism and are closely associated with intracellular homeostasis [29]. Previous studies have indicated that the C4BPA gene plays a significant role in lipid and glucose metabolism in BMECs. To further investigate the pathway through which C4BPA knockout suppresses the inflammatory response, we employed immunofluorescence and observed colocalization between C4BPA and mitochondria. In addition, electron microscopy revealed an increase in autolysosomes within BMECs following C4BPA gene knockout. Mitophagy is an important lysosomal degradation pathway that removes damaged or unnecessary mitochondria to maintain cellular and organismal homeostasis [30]. The mitochondrial respiratory chain are the major sources of ROS production, but excessive ROS can cause mitochondrial structural damage and functional loss [31,32]. Duan et al. [33] reported that microcystin-LR (MC-LR) exposure caused ATP depletion, ROS accumulation, impaired oxidative phosphorylation, and mitophagy activation in stromal vascular fraction (SVF) cells. In our study, a flow cytometry analysis revealed an increase in ROS levels within BMECs following C4BPA gene deletion. This suggests that the absence of the C4BPA gene triggered mitophagy.
The regulation of Pink1-/Parkin-mediated mitophagy has been widely studied [34]. When mitochondria are damaged, Pink1 and Parkin in the cytoplasm ubiquitinate and bind to the outer membrane of the damaged mitochondria and then to LC3-II on the phagophore membrane to form a mitochondrial autophagosome and be degraded by lysosomes [35,36]. Xia et al. [37] demonstrated that kaempferol could reactivate mitophagy by increasing the expression levels of Pink1, Parkin, and LC3 and reducing p62 expression in a rat model of diabetic kidney disease (DKD). Qin et al. [38] found that platycodin D could promote the expression levels of Pink1, Parkin, and LC3B-II through the AMPK pathway, activate mitochondrial autophagy by downregulating P62 expression, and inhibit the NF-κB signalling pathway by reducing the phosphorylation levels of P-p65/p65 and P-p38/p38, thereby synergistically regulating diabetic ischemia/reperfusion injury. Therefore, the increased Pink1 and Parkin expressions, decreased P62 expression, increased LC3B-I-to-LC3B-II conversion, and increased LC3 colocalization with mitochondria in mammary epithelial cells from C4BPA knockout cows that we observed in the present study suggest that C4BPA knockout promotes mitophagy to remove damaged mitochondria.
Mitochondrial damage can activate the NF-κB signalling pathway, thereby inducing an inflammatory response [39]. This pathway serves as a critical link between external stimuli and the expression of inflammatory genes. Its activation is contingent upon the phosphorylation of the IκB kinase (IKK) complex, which leads to the degradation of IκBα and the subsequent release of the NF-κB p65 subunit into the nucleus to regulate the transcription of target genes [40]. Mayra et al. [41] demonstrated that C4BPA binds specifically to the CD40 molecule through its C-terminal domain, activating the noncanonical NF-κB signalling pathway in placental tissues. In the present study, the expression levels of P-p65/p65 and P-IκBα/IκBα decreased significantly after C4BPA gene knockout, indicating that NF-κB signalling pathway activation was inhibited. This coincides with the suppression of the inflammatory response by reducing the expression of the inflammatory factors mentioned above. In addition, Huang et al. [42] reported that TJ0113 reduced lipid accumulation, inflammation, and fibrosis in the liver of nonalcoholic steatohepatitis (MASH) mice by inducing mitophagy through the Pink1/Parkin signalling pathway and inhibiting the NF-kB/NLRP3 signalling pathway. Liu et al. [43] demonstrated that Staphylococcus aureus infection of bovine mammary epithelial cells activates Pink1-/Parkin-mediated mitophagy and suppresses the NF-κB signalling pathway by reducing the P-p65 and P-IκBα (as indicated by decreased P-p65/p65 and P-IκBα/IκBα ratios), thereby attenuating the inflammatory response. Therefore, we propose that knockout of the C4BPA gene alleviates the inflammatory response by promoting mitophagy and suppressing the NF-κB signalling pathway.
The release of ROS is a vital component of the inflammatory response [16]. Moreover, the production of ROS increases in BMECs, which damages mitochondria in dairy cows with Klebsiella pneumoniae-induced mastitis [44]. Therefore, ROS and inflammatory responses are mutually reinforcing. However, in the present study, we found that after knockout of the C4BPA gene, ROS levels increased, while the levels of inflammatory factors decreased. This may be because the relationship between ROS levels and the inflammatory response involves the regulation of multiple genes. After C4BPA knockout, the functions of other genes may be altered, resulting in elevated ROS levels and downregulated expression of inflammatory factors. In addition, the factors triggering cellular inflammatory responses are diverse. Mitochondrial dysfunction has been identified as a significant contributing factor to the establishment of a chronic inflammatory response [45]. Mitochondrial DNA-dependent activation of endolysosomal TLR9 or cytoplasmic inflammasomes can generate pro-inflammatory responses [46]. Jiang et al. [47] reported that ROS are upstream activators of dynamin-related protein 1 (Drp1) and that their increase can activate Drp1 by promoting mitophagy to form ROS–DRP1–mitophagy feedback during myogenic differentiation. Mitophagy can clear damaged mitochondria and mitochondrial DNA within cells, thus reducing the substrate availability for inflammatory responses [48]. Based on the above findings, we hypothesize that knockout of the C4BPA gene leads to increased ROS levels, which promote mitophagy to clear damaged mitochondria, thereby reducing the pro-inflammatory factors levels and suppressing the inflammatory response. However, this hypothesis requires further experimental validation.
It should be acknowledged that our study has certain limitations. Although our electron microscopy results indicate an association between C4BPA loss and altered mitochondrial morphology, the absence of process-specific controls for the knockout model means we cannot rule out the possibility that these morphological changes may potentially arise from the experimental procedure itself. Further validation employing targeted interventions and in vivo experiments will be conducted in future studies.
5. Conclusions
Knockout of the C4BPA gene in bovine mammary epithelial cells not only promotes mitophagy via activation of the Pink1/Parkin pathway but also alleviates the inflammatory response by inhibiting the NF-κB pathway.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Noris M. Remuzzi G. Overview of Complement Activation and Regulation Semin. Nephrol.20133347949210.1016/j.semnephrol.2013.08.00124161035 PMC 3820029 · doi ↗ · pubmed ↗
- 2Rainard P. The Complement in Milk and Defense of the Bovine Mammary Gland against Infections Vet. Res.20033464767010.1051/vetres:200302514556699 · doi ↗ · pubmed ↗
- 3Zipfel P.F. Skerka C. Complement Regulators and Inhibitory Proteins Nat. Rev. Immunol.2009972974010.1038/nri 262019730437 · doi ↗ · pubmed ↗
- 4KadaváT. Hevler J.F. Kalaidopoulou Nteak S. Yin V.C. Strasser J. Preiner J. Heck A.J. Higher-Order Structure and Proteoforms of Co-Occurring C 4b-Binding Protein Assemblies in Human Serum EMBO J.2024433009302610.1038/s 44318-024-00128-y 38811852 PMC 11251186 · doi ↗ · pubmed ↗
- 5Criado-García O. Fernaud-Espinosa I. Bovolenta P. De La Cuesta R.S. De Córdoba S.R. Expression of the β-chain of the complement regulator C 4b-binding protein in human ovary Eur. J. Cell Biol.19997865766410.1016/S 0171-9335(99)80051-X 10535308 · doi ↗ · pubmed ↗
- 6Olcina M.M. Kim R.K. Balanis N.G. Li C.G. Von Eyben R. Graeber T.G. Ricklin D. Stucki M. Giaccia A.J. Intracellular C 4BPA Levels Regulate NF-κB-Dependent Apoptosisi Science 20202310159410.1016/j.isci.2020.10159433205012 PMC 7648136 · doi ↗ · pubmed ↗
- 7Guo W. Liu J. Li W. Ma H. Gong Q. Kan X. Cao Y. Wang J. Fu S. Niacin Alleviates Dairy Cow Mastitis by Regulating the GPR 109A/AMPK/NRF 2 Signaling Pathway Int. J. Mol. Sci.202021332110.3390/ijms 2109332132397071 PMC 7246865 · doi ↗ · pubmed ↗
- 8Krishnamoorthy P. Goudar A.L. Suresh K.P. Roy P. Global and Countrywide Prevalence of Subclinical and Clinical Mastitis in Dairy Cattle and Buffaloes by Systematic Review and Meta-Analysis Res. Vet. Sci.202113656158610.1016/j.rvsc.2021.04.02133892366 · doi ↗ · pubmed ↗
